MC1935A1 - Procedes pour la preparation d'arabinosides puriques substitues,de leurs derives pharmaceutiquement acceptables et de formulations pharmaceutiques les contenant - Google Patents

Procedes pour la preparation d'arabinosides puriques substitues,de leurs derives pharmaceutiquement acceptables et de formulations pharmaceutiques les contenant

Info

Publication number
MC1935A1
MC1935A1 MC881981A MC1981A MC1935A1 MC 1935 A1 MC1935 A1 MC 1935A1 MC 881981 A MC881981 A MC 881981A MC 1981 A MC1981 A MC 1981A MC 1935 A1 MC1935 A1 MC 1935A1
Authority
MC
Monaco
Prior art keywords
compound
formula
purine
methoxy
arabinofurannosyl
Prior art date
Application number
MC881981A
Other languages
English (en)
French (fr)
Inventor
A Krenitsky T
W Koszalka G
A Jones L
R Averett D
R Moorman A
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of MC1935A1 publication Critical patent/MC1935A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Plant Substances (AREA)
MC881981A 1987-05-30 1988-05-27 Procedes pour la preparation d'arabinosides puriques substitues,de leurs derives pharmaceutiquement acceptables et de formulations pharmaceutiques les contenant MC1935A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878712745A GB8712745D0 (en) 1987-05-30 1987-05-30 Antiviral compounds

Publications (1)

Publication Number Publication Date
MC1935A1 true MC1935A1 (fr) 1989-05-19

Family

ID=10618179

Family Applications (1)

Application Number Title Priority Date Filing Date
MC881981A MC1935A1 (fr) 1987-05-30 1988-05-27 Procedes pour la preparation d'arabinosides puriques substitues,de leurs derives pharmaceutiquement acceptables et de formulations pharmaceutiques les contenant

Country Status (31)

Country Link
US (2) US5424295A (cs)
EP (1) EP0294114B1 (cs)
JP (1) JP2667873B2 (cs)
KR (1) KR970009474B1 (cs)
CN (1) CN1020107C (cs)
AT (1) ATE142636T1 (cs)
AU (1) AU622403B2 (cs)
CA (1) CA1330990C (cs)
CS (1) CS277006B6 (cs)
CY (2) CY2001A (cs)
DD (2) DD293962A5 (cs)
DE (2) DE3855522T2 (cs)
DK (1) DK171670B1 (cs)
ES (1) ES2091750T3 (cs)
FI (1) FI89805C (cs)
GB (1) GB8712745D0 (cs)
GR (1) GR3021257T3 (cs)
HK (1) HK78497A (cs)
HU (2) HU199870B (cs)
IL (1) IL86531A (cs)
LU (1) LU91370I2 (cs)
MC (1) MC1935A1 (cs)
MY (1) MY103567A (cs)
NL (1) NL300302I2 (cs)
NO (2) NO172543C (cs)
NZ (1) NZ224813A (cs)
PH (1) PH27292A (cs)
PL (1) PL157684B1 (cs)
PT (1) PT87592B (cs)
SA (1) SA99200688A (cs)
ZA (2) ZA883829B (cs)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8712745D0 (en) * 1987-05-30 1987-07-01 Wellcome Found Antiviral compounds
US7307166B1 (en) * 1987-10-28 2007-12-11 Wellstat Therapeutics Corporation Oxpurine nucleosides and their congeners, and acyl, derivatives thereof, for improvement of hematopoiesis
DD293498A5 (de) * 1989-07-20 1991-09-05 Zi Fuer Molekularbiologie Der Adw,De Verfahren zur herstellung eines mittels fuer die behandlung oder prophylaxe von hepatits-infektionen bei mensch und tier
US6337209B1 (en) 1992-02-26 2002-01-08 Glaxo Wellcome Inc. Molecular constructs containing a carcinoembryonic antigen regulatory sequence
GB8919607D0 (en) 1989-08-30 1989-10-11 Wellcome Found Novel entities for cancer therapy
KR910007655A (ko) * 1989-10-03 1991-05-30 엠. 피. 잭슨 치료용 뉴클레오시드
US5206351A (en) * 1990-06-15 1993-04-27 Ash Stevens, Inc. Process for the preparation of 2-amino (2,3,5-tri-o-benzyl-beta-d-arabinofuranosyl)adenine
GB9015914D0 (en) * 1990-07-19 1990-09-05 Wellcome Found Heterocyclic compounds
US5283331A (en) * 1990-12-20 1994-02-01 Nippon Kayaku Kabushiki Kaisha 2-halogeno-oxetanocin A and phosphoric ester thereof
GB9104165D0 (en) * 1991-02-27 1991-04-17 Wellcome Found Novel entities for hiv therapy
US5961987A (en) * 1996-10-31 1999-10-05 University Of Iowa Research Foundation Ocular protein stimulants
JP3619017B2 (ja) 1998-06-24 2005-02-09 日本臓器製薬株式会社 新規アラビノシルアデニン誘導体
US6653318B1 (en) 1999-07-21 2003-11-25 Yale University 5-(E)-Bromovinyl uracil analogues and related pyrimidine nucleosides as anti-viral agents and methods of use
ATE332910T1 (de) * 2000-02-18 2006-08-15 Southern Res Inst Verfahren zur herstellung von 2-chloro-9-(2-deoxy-2-fluoro-beta-d-arabinofura osyl)-9h-purin-6-amin
US6753322B2 (en) * 2000-06-06 2004-06-22 Pfizer Inc 2-aminocarbonyl-9H-purine derivatives
JP3421330B2 (ja) * 2000-11-02 2003-06-30 持田製薬株式会社 ビダラビン注射用乾燥製剤
EA008380B1 (ru) 2001-11-27 2007-04-27 Анадис Фармасьютикалз, Инк. 3-β-D-РИБОФУРАНОЗИЛТИАЗОЛО[4,5-d]ПИРИМИДИННУКЛЕОЗИДЫ И ИХ ПРИМЕНЕНИЯ
US7321033B2 (en) * 2001-11-27 2008-01-22 Anadys Pharmaceuticals, Inc. 3-B-D-ribofuranosylthiazolo [4,5-d] pyrimidine nucleosides and uses thereof
AU2003279797B2 (en) * 2002-09-30 2009-10-22 Genelabs Technologies, Inc. Nucleoside derivatives for treating hepatitis C virus infection
CN102504001B (zh) 2004-12-17 2015-02-25 安那迪斯药品股份有限公司 3,5-二取代的和3,5,7-三取代的-3H-噁唑并以及3H-噻唑并[4,5-d]嘧啶-2-酮化合物及其前药
US20060178512A1 (en) * 2005-02-04 2006-08-10 Cheruthur Govindan Method for preparing amino acid esters of nucleoside analogues
SG152296A1 (en) 2005-11-21 2009-05-29 Anadys Pharmaceuticals Inc Novel process for the preparation of 5-amino-3h-thiazolo[4,5-d]pyrimidin-2- one
MX2008016518A (es) * 2006-06-22 2009-01-19 Anadys Pharmaceuticals Inc Profarmacos de 5-amino-3-(3'-desoxi-beta-d-ribofuranosil)-tiazolo[ 4,5-d]pirimidin-2,7-dion.
WO2008011406A2 (en) 2006-07-18 2008-01-24 Anadys Pharmaceuticals, Inc. Carbonate and carbamate prodrugs of thiazolo [4,5-d] pyrimidines
CN101092441A (zh) * 2007-07-17 2007-12-26 北京本草天源药物研究院 一种奈拉滨的合成方法
US7846912B2 (en) * 2007-09-13 2010-12-07 Protia, Llc Deuterium-enriched nelarabine
CN101768197A (zh) * 2008-12-29 2010-07-07 北京德众万全药物技术开发有限公司 一种奈拉滨的制备方法
CN103665076B (zh) * 2012-08-30 2018-01-09 上海阳帆医药科技有限公司 奈拉滨的制备方法
CN104892709B (zh) * 2015-06-04 2018-01-19 新乡学院 一种合成奈拉滨的方法
WO2018133835A1 (en) * 2017-01-20 2018-07-26 National Institute Of Biological Sciences, Beijing Nucleoside analogue regulating mammalian circadian rhythm
CN115279891B (zh) * 2021-06-09 2024-11-22 正大天晴药业集团股份有限公司 用于制备奈拉滨的重组基因工程菌及其应用
WO2022258014A1 (zh) * 2021-06-09 2022-12-15 正大天晴药业集团股份有限公司 用于制备奈拉滨的重组基因工程菌及其应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759011A (fr) * 1969-11-17 1971-05-17 Wellcome Found Aminopurines
US3758684A (en) * 1971-09-07 1973-09-11 Burroughs Wellcome Co Treating dna virus infections with amino purine derivatives
US4048432A (en) * 1976-05-17 1977-09-13 Parke, Davis & Company 9-(3,5-Di-O-acyl-β-D-arabinofuranosyl)adenine compounds and method for their production
US4055718A (en) * 1976-05-17 1977-10-25 Parke, Davis & Company 9-(2-O-Acyl-β-D-arabinofuranosyl)-adenine compounds and method for their production
US4055717A (en) * 1976-05-17 1977-10-25 Parke, Davis & Company 9-(3-O-Acyl-β-D-arabinofuranosyl)adenine compounds, 9-(2,3-di-O-acyl-β-D-arabinofuranosyl)-adenine compounds, and method for their production
US4371613A (en) * 1977-08-10 1983-02-01 Ajinomoto Company Incorporated Method for producing purine arabinosides
JPS6053941B2 (ja) * 1977-08-10 1985-11-28 日本電気株式会社 バイアスライト駆動方式
JPS5515716A (en) * 1978-07-18 1980-02-04 Ajinomoto Co Inc Production of purine arabinoside
GB1573777A (en) * 1977-11-03 1980-08-28 Wellcome Found 9-d-arabinonucleosides and an enzymatic process for their preparation
US4495180A (en) * 1982-06-21 1985-01-22 Merck & Co., Inc. Prodrugs of Ara-A an antiviral agent
JPS58225097A (ja) * 1982-06-23 1983-12-27 Yamasa Shoyu Co Ltd ヌクレオシド５′−アルキルもしくはアルケニルりん酸
CA1285935C (en) * 1985-03-16 1991-07-09 Janet Lister Rideout Therapeutic nucleosides
GB8712745D0 (en) * 1987-05-30 1987-07-01 Wellcome Found Antiviral compounds

Also Published As

Publication number Publication date
US5539098A (en) 1996-07-23
CY2008001I2 (el) 2009-11-04
GB8712745D0 (en) 1987-07-01
CS8803635A2 (en) 1990-09-12
PT87592A (pt) 1989-05-31
SA99200688A (ar) 2005-12-03
NZ224813A (en) 1991-04-26
HU205001B (en) 1992-03-30
NO2007016I1 (no) 2008-01-14
US5424295A (en) 1995-06-13
CA1330990C (en) 1994-07-26
NL300302I1 (nl) 2008-01-02
DE122008000003I1 (de) 2008-04-17
PH27292A (en) 1993-05-04
IL86531A (en) 1993-07-08
HUT47129A (en) 1989-01-30
HK78497A (en) 1997-06-20
ATE142636T1 (de) 1996-09-15
JPS63310831A (ja) 1988-12-19
NO882357D0 (no) 1988-05-27
GR3021257T3 (en) 1997-01-31
CS277006B6 (en) 1992-11-18
PT87592B (pt) 1992-09-30
DE3855522D1 (de) 1996-10-17
DK171670B1 (da) 1997-03-10
CN1020107C (zh) 1993-03-17
CN1031233A (zh) 1989-02-22
AU622403B2 (en) 1992-04-09
EP0294114A2 (en) 1988-12-07
ZA897598B (en) 1990-01-31
LU91370I2 (fr) 2007-12-10
ES2091750T3 (es) 1996-11-16
DK289788A (da) 1988-12-01
IL86531A0 (en) 1988-11-15
DD282694A5 (de) 1990-09-19
NO172543C (no) 1993-08-04
HU199870B (en) 1990-03-28
DK289788D0 (da) 1988-05-27
DD293962A5 (de) 1991-09-19
EP0294114B1 (en) 1996-09-11
CY2001A (en) 1997-12-05
PL157684B1 (pl) 1992-06-30
FI89805B (fi) 1993-08-13
CY2008001I1 (el) 2009-11-04
NO2007016I2 (no) 2008-06-23
MY103567A (en) 1993-08-28
DE3855522T2 (de) 1997-02-06
ZA883829B (en) 1990-01-31
EP0294114A3 (en) 1990-01-24
AU1671888A (en) 1988-12-01
NO172543B (no) 1993-04-26
KR880013967A (ko) 1988-12-22
HU895829D0 (en) 1990-01-28
NO882357L (no) 1988-12-01
FI89805C (fi) 1993-11-25
JP2667873B2 (ja) 1997-10-27
KR970009474B1 (ko) 1997-06-13
FI882511L (fi) 1988-12-01
NL300302I2 (nl) 2008-05-01
FI882511A0 (fi) 1988-05-27
DE122008000003I2 (de) 2010-02-04
PL272729A1 (en) 1989-02-06

Similar Documents

Publication Publication Date Title
MC1935A1 (fr) Procedes pour la preparation d'arabinosides puriques substitues,de leurs derives pharmaceutiquement acceptables et de formulations pharmaceutiques les contenant
DE69815378T2 (de) Adenosin a1-rezeptor agonisten
TW420663B (en) Indole compounds for cyclic nucleotide-PDEs inhibitors
MC1068A1 (fr) Derives de la purine et medicaments qui en contienprocede de preparation de derives de la purine nent
HRP20000275A2 (en) Chemical compounds
EP0539479B1 (en) Heterocyclic compounds
CA2102782C (en) 2-fluoro-2-substituted adeninyl arabinosides as anti-cancer agents
MC1475A1 (fr) Procede de preparation de derives de la purine a action anti-virale
MC1915A1 (fr) Procédés pour la préparation de 2',3'-didésoxynucléosides et de formulations pharmaceutiques en contenant
MC869A1 (fr) Furanosyl-aminopurines et médicament contenant ces substances
JPH07502740A (ja) 治療用ヌクレオシド
CN117797146A (zh) Sarm1酶活性抑制剂及其在神经退行性疾病中的应用
JPH0560478B2 (cs)
JPH0217199A (ja) ２’−デオキシ−β−アデノシンの製造方法
JPH0232094A (ja) 抗感染性ヌクレオシド
RU2112765C1 (ru) ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ПРОЯВЛЯЮЩАЯ АКТИВНОСТЬ ПРОТИВ ВИРУСНОЙ ИНФЕКЦИИ И β D-АРАБИНОФУРАНОЗИЛ-2-АМИНО-6-МЕТОКСИ-9Н-ПУРИНЫ
RU2039752C1 (ru) Способ получения замещенных пуриновых арабинозидов или его фармацевтически приемлемых производных
WO2008007027A1 (fr) Nouveaux derives de 5-thioxylopyranose
EP0060099A1 (en) Antiviral agents, their preparation and use
AU641533C (en) Heterocyclic compounds
EP0095292A1 (en) 5-(2-halogenovinyl)-2'-deoxyuridine derivatives, processes for their preparation, pharmaceutical compositions containing them, and their use in treating viral infections"
MXPA00004429A (en) Adenosine a1 receptor agonists

Legal Events

Date Code Title Description
YP Annual fee paid